Business Standard
Sunday, Jan 29, 2012
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
||Companies & Industry||||||| 
 Section Home | News Now | Today's Paper | Q&A | People in the News | Industry News | Features | The Compass | Research & Analysis | Opinion | Corporate Results
Home > Companies & Industry Live Markets | Commodities
 

Cipla ties up with Stempeutics for stem cell therapies
BS Reporter / Mumbai Apr 28, 2010, 00:57 IST

Cipla, the largest domestic drug manufacturer, has tied up with the Manipal Group-promoted Stempeutics Research to market stem cell-based therapies.

Cipla will fund Rs 50 crore within the next two years to conduct clinical trials and to further develop two products being worked on by Stempeutics. Cipla will further invest to develop more products and in return will get marketing rights on a transfer pricing basis during commercialisation, said B N Manohar, president, Stempeutics.

Cipla
BSE | NSE
Price  
Cipla
Clinical trials, involving human volunteers, are to test drugs in human beings for ensuring safety and efficacy and to detect side effects. Stem cells would be a major branch of medical treatment and would be a standard of cure and practice in the years to come and this would be an ideal supplement for existing medical treatments, said Amar Lulla, joint managing director of Cipla.

“We chose Stempeutics for their strength in developing world-class stem cell products, starting from basic research, pre-clinical studies, large scale upscaling and conducting multi centric clinical studies as per international standards,” he said.

Six years ago, Cipla had entered into a similar agreement with Bangalore-based Avesthagen to access its bio-pharmaceutical products under development. “In the last four-five years, we invested about Rs 65 crore and require another Rs 50 crore for conducting clinical trials and registrations in India and abroad,” said Manohar for Stempeutics. “The first product is likely to reach the market by 2013.”

The expected current stem cell therapy market in India is about $540 million (Rs 2,395 crore) and will grow rapidly, said Jaideep Gogtay, medical director, Cipla. Stempeutics is currently developing eight stem cell based therapies. Of this, two products are under clinical trial in India and another two in Malaysia.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Wall Street opens lower after GDP data
- General VK Singh's DoB to be corrected
- Babus in poll fray, EC asks govt to bar them
- 'Cabinet nod may not be required for PSU share buyback'
- MoEF rejects clearance to NMDC's Bailadila mine
  Read Business news in 
- Now property search gets more exciting than ever before!
- Live Free in Your Own Home. Click here to know more..
- Office 365 for professionals and small businesses.
- Improve Patient Care & Experience. Click here to know more
- Are You Serious About Your Future? Click here to know more
- Special moments captured with VIVID clarity. Know more..
- Give your Health the Max Bupa Protection.
- Special moments captured with VIVID clarity. Know more..
- Need Technologies to achieve your vision?
- The loan is available at very competitive rates of interest.
- Win a Business Class Ticket to Europe..Know more..
- Double your Fixed Deposit amount in just 7 1/2 years...
- Get your business a free website.. know more.
- A hassle free reservation with our Best Available Rate.
-  Introduce a New Automotive Luxury Car.. know more
- Health is Wealth..... Insurance + Savings... Know More...
- Invest in Real Estate. Villas in B?lore starting @ Rs.66 lacs
- A brand new server at a price that fits your budget.
Sorry, comments to this story are closed
Latest Messages
Posted by: caroline Carr-Locke
is there anyone anywhere that knows if stem cells could help me in my condition of IDIOPATHIC AXONaL PERIPHERAL NEUROPATHY There is no research in Scotland/uk where i live no help whatsoever Anyone know if medical trials for this condition i am fit 66 year old who was diagnosed with this condition 18 months ago all blood tests lumbar puncture are normal only nerve conduction tests show i have a problem willing to travel anywhere
    Posted by: anthony
contact reelabs in india based at mumbai, they r offering stemcells therapy for so many chronic diseases. contact no.-+919820121848
SmartInvestor+ E-zine
  Pay Rs.747/- for 3 years and
  get a branded watch FREE

  Subscribe Now
Most Popular
Read
E-Mailed
Commented
   
- Wkly Tech Analysis: Markets likely to turn choppy
- A K Bhattacharya: The decline of Davos?
- Sreelatha Menon: Skilling the jawans
- Govt keeps eye on infra projects
- Gas supply choke cuts Dabhol output by 900 Mw
 
 More  
BUSINESS STANDARD INDIA 2012
  Now available at Special price
  Rs.395/- Only

  Buy Now
  BS Specials  
    Full coverage of elections in Uttar Pradesh, Punjab, Uttarakhand, Manipur and Goa
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
FOR HOT PRODUCTS
BS Bazaar.com
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us